Faron, etusivu

releases and announcements

Traumakine update - YODA results

Regulatory

First patient dosed in phase I/II MATINS study

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Patient subgroup identified from INTEREST trial

Regulatory

Faron receives CTA approval for Clevegen

Regulatory

PDMR Dealings

Insider Transaction Regulatory

INTEREST trial update presented at ESICM

Regulatory

Director/PDMR Shareholding

Insider Transaction Regulatory

Faron announces CTA filing for Clevegen

Regulatory

New data published on Clever-1 function

Regulatory
PreviousNext
Back to top